submit your manuscript | www.dovepress.com Abstract: Cell therapy is a promising approach to treating spinal cord injury (SCI). Previous studies demonstrated that co-transplantation of human umbilical cord mesenchymal stem cells (hUC-MSCs) and human Schwann cells (hSCs) was an effective strategy by which to promote the regeneration of corticospinal fibers and locomotor recovery after SCI in rats. However, the neural differentiation potential of hUC-MSCs was not fully understood. In the present study, we examined the influence of hSCs on the survival and differentiation of hUC-MSCs in SCI rats. Four groups of rats were implanted with Dulbecco's Modified Eagle's Medium (DMEM), hSCs, hUC-MSCs, or a combination of hSCs and hUC-MSCs, respectively. Our results demonstrated that MAB1281 immunopositive cells appeared in the injured site of the transplanted cell groups, while myelin basic protein and high-molecular-weight neurofilament immunopositive cells were detected only in the co-transplantation group under the positive background of MAB1281. Furthermore, polymerase chain reaction (PCR) and Western blot showed significantly higher expression of myelin basic protein and high-molecular-weight neurofilament and lower expression of glial fibrillary acidic protein in the co-transplantation group (P , 0.05), which correlated strongly with immunofluorescence findings. These results suggest that hSCs could induce hUC-MSC differentiation into neurons and oligodendrocytes and inhibit the formation of glial scarring after SCI. The neural differentiation of hUC-MSCs is likely induced by soluble factors provided by hSCs.
Introduction
People suffering from spinal cord injury (SCI) are prone to permanent paralysis and disability due to the limited regenerative ability of the cord. Self-restoration is greatly decreased because of an absolute loss of neurons and glia. Cell transplantation, as a therapeutic approach in SCI, has attracted much research attention because the transplanted cells possess an ability to accommodate the need for cell replacement. Schwann cells (SCs), the myelin-forming glial cells of the peripheral nervous system, 1 play a key role in Wallerian degeneration and subsequent regeneration. 2 Zurita et al obtained evidence that SCs could promote the neural differentiation of bone marrow stromal cells 3 due to the release of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF). 4, 5 Human umbilical mesenchymal stem cells (hUC-MSCs), another promising stem cell, could be more easily obtained and processed than embryonic or bone marrow stromal cells. Previous studies have proven that the transplanted hUCMSCs could trigger axons to grow across the permissive-inhibitory border and promote
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Wu et al recovery of hind limb locomotor function in injured rats. 6, 7 hUC-MSCs are capable of differentiating into osteogenic, adipogenic, myogenic, and neuron-like cells in vitro. 8, 9 The repair ability and axonal differentiation potential of hUCMSCs, however, is not sufficient to allow substantial recovery following SCI. 9, 10 Although Zhu et al previously demonstrated that co-transplantation of autologous activated SCs and hUC-MSCs could effectively promote the regeneration of corticospinal fibers and the recovery of locomotor function after SCI, 11 their findings did not provide evidence that SCs could induce the neural differentiation of hUC-MSCs.
This study was carried out to investigate the possible influence of human SCs (hSCs) on the survival and differentiation of hUC-MSCs in SCI rats as well as the expression change of glial fibrillary acidic protein (GFAP), myelin basic protein (MBP), and high-molecular-weight neurofilament (NF-H).
Materials and methods animal groups
Sixty adult Wistar rats (female, 250 ± 10 g, provided by Radiation Study Institute-Animal Center, Tianjin, People's Republic of China) were randomly and evenly assigned to four experimental groups (15 adult rats in each group), which were as follows: group A, Dulbecco's Modif ied Eagle's Medium (DMEM) control group; group B, hSC transplantation group; group C, hUC-MSC transplantation group; and group D, hSC and hUC-MSC co-transplantation group.
Cell culture and purification
For culture of SCs, the stump sciatic nerves were obtained under aseptic condition from those patients who had lower limbs amputated. After the epineurium of the nerve tissue was peeled off, the remaining nerve tissue was cut into small pieces (0.5∼1 mm 3 ). The tissue lumps were digested with trypsin (College of Life Sciences, Nankai University, Tianjin, People's Republic of China) for 20-30 minutes and then attached to the bottom of 6-well culture plates precoated with polylysine. hSCs were propagated in DMEM supplemented with 10% fetal bovine serum. The cells were incubated at 37.8°C, 5% CO 2 ; the culture medium was replaced every 3 days. When hSCs reached confluence of 90%, fifth-passage cells were induced. The cells were purified by differential adhesion. After five passages, the purity of hSCs was identified by S-100 (Boster Biological Technology, Ltd., Wuhan, People's Republic of China) immunostaining and the number of S-100-positive cells and total cells were counted under fluorescence microscopy. After five passages, cells with a density of 1.0 × 10 5 /µL were used in this experiment.
hSC purity (%) = S-100-positive cells/ total cells × 100%. [1] hUC-MSCs were donated by the Tianjin Union Stem Cell and Gene Engineering Co., Ltd (Tianjin, People's Republic of China) and cells with a density of 1.0 × 10 5 /µL were used in this experiment.
Identification of SCs
hSCs were cultured on a cover slip for 48 hours, washed three times with 0.01 M phosphate-buffered solution (PBS), and then postfixed with 4% paraformaldehyde (pH 7.4) for 4 hours at room temperature. The cell cover slip was then covered with 0.1% Triton X-100 for 15 minutes at room temperature and blocked with 5% goat serum albumin for 10 minutes to block the nonspecific antigen. Primary antibody (rabbit anti-rat S-100 immunoglobulin [Ig]G 1:50; SigmaAldrich, St Louis, MO, USA) was added to the slides, which were then incubated at 37°C for 30 minutes. Secondary antibody (goat anti-rabbit IgG/FITC 1:100; Sigma-Aldrich) was added to the slides for 10 minutes at 37°C. The slides were observed with fluorescence microscopy.
Preparation for sci model and cell grafting
The Wistar rats were anesthetized by intraperitoneal injection with 10% chloral hydrate (0.33 mL/100 g). The surgical area was shaved and disinfected with iodophor. The spinous process and vertebral plate were removed using a microrongeur (Aesculap AG, Tuttlingen, Germany) at T10 and the dura was opened. Then, the NYU impactor machine (WM Keck Center for Collaborative Neuroscience, Piscataway Township, NJ, USA) was used to hit the exposed spinal cord with 10 g × 50 mm weight drop. A total of 10 µL DMEM, 5 µL hSC cell suspension plus 5 µL DMEM, 5 µL hUC-MSCs plus 5 µL DMEM, 5 µL hSC plus 5 µL hUCMSCs suspension (with a cell density of 1.0 × 10 5 /µL) was injected into the 1 cm length caudal and rostra to the SCI site with a Hamilton injector (Shanghai Precision and Scientific Instrument Co., Ltd, Shanghai, People's Republic of China) at a 45° angle. After the injection, the needle was indwelled for 3 minutes, after which the incision was sutured layer by layer. After surgery, rats were placed in temperature-and humidity-controlled incubation chambers until they awoke. They were then transferred to cages, and bladder evacuation 
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hscs promoting neural differentiation of hUc-Mscs in spinal cord injury was performed daily until return of reflexive bladder control. Three days before cell grafting, the rats were injected with cyclosporine A (10 mg/kg) until the end of the experiment.
histological analysis
Rats were sacrificed with an overdose of 10% chloral hydrate by intraperitoneal injection and perfused transcardially with 4% neutral PFA in 0.01 M PBS, pH 7.4, 2 and 4 weeks after the cell grafting, respectively. A 1.5 cm length of the spinal cord centered at the injury site was separated and embedded in a paraffin-embedding machine (Leica Microsystems, Wetzlar, Germany). Paraffin sections (5 µm) were cut with microtome (Leica Microsystems) and mounted onto gelatinsubbed slides. For immunostaining, we picked up one of the 15th to 20th slices, including the injured area from dorsal to ventral side of the spinal cord, to reduce the influence of error. Three coronal sections in each group were used for hematoxylin and eosin staining. Six cross-sections in each group were stained for GFAP, MBP, and NF-H (Santa Cruz Company, CA, USA) immunoreactivity staining, respectively.
Western blotting
Rats were randomly sacrificed in each group as per the method described above. One hundred fifty micrograms of the immunoblotting tissue was lysed in ice-cold lysis buffer. The homogenate was centrifuged at 12,000 r for 20 minutes at 4°C, then the supernatants were collected and heated at 100°C for 5 minutes. Protein (20 µL/well) was loaded in sodium dodecyl sulfate-polyacrylamide gel electrophoresis and run in running buffer. Gels were transferred to nitrocellulose membrane. The membranes were blocked with 5% nonfat skim milk in PBS and then incubated with primary antibodies overnight at 4°C. The following morning, blots were processed with horseradish peroxidase-conjugated secondary antibodies for 2 hours at room temperature. β-actin antibody was used as an internal control.
real-time polymerase chain reaction (Pcr)
For real-time PCR (LightCycler ® ; Bio-Rad Laboratories, Inc., Hercules, CA, USA), the spinal cord (about 25 µg) was removed at the caudal and rostra of the injury site. Each RNA sample (2 µg total) was extracted with an RNA extraction kit (QIAGEN Co. Ltd., Shanghai, People's Republic of China) for reverse transcription reaction, according to the manufacturer's instructions. The acquired complementary DNA (cDNA) was used for the real-time PCR. The reaction system (total 25 µL) included 2 µL cDNA, 8.5 µL ddH 2 O 2 , 1 µL 10 pm upstream primer, 1 µL downstream primer, and 12.5 µL SYBR Green fluorescent dye (Table 1 ). The amplification conditions were 95°C for 3 minutes; 40 cycles of 95°C for 15 seconds, 60°C for 20 seconds, and 72°C for 20 seconds; 95°C for 1 minute and 60°C for 1 minute; and 60°C to 95°C and again to 60°C for 71 cycles. The run was completed with descending to 25°C. The control experiments were carried out with GADPH.
Data analysis
Data were analyzed with SPSS software (v 16.0; IBM Corporation, Armonk, NY, USA) and presented as mean ± standard deviation. The different time comparisons among each group were analyzed by analysis of variance (ANOVA) and SNK-q. Statistical significance was set at P , 0.05.
Results
Culture, purity, and identification of hSCs
Three days after the primary passage culture, a few SCs showed outside the rim of the tissue lumps and showed a spindle shape under the microscope ( Figure 1A ). Within the following 5 days, the cells proliferated and covered the entire bottom of the 6-well plates. The outlines of the hSCs were clear and bright, with some of the cells presenting with a whirlpool shape. After purification by differential adhesion method, the cells were arranged side-by-side and demonstrated directionality; the morphous of hSCs appeared more unified; and the number of fibroblasts had decreased obviously ( Figure 1B) . After five passages, the hSCs exhibited stable expression of S-100 antigen and the purity of hSCs reached more than 90% ( Figure 1C) Biological characters of hUc-Mscs hUC-MSCs appear as spherical, star-like, or elongated flat fibroblast like morphology with granules on the surfaces that have neither protrusions nor networks between the cells. 
Observation of immunofluorescence staining
Four weeks after cell grafting, on the background of MAB1281, immunofluorescence staining of neural (NF-H) and oligodendroglial (MBP) cells was positive in group D, while immunofluorescence expression of MBP and NF-H was absent in the other groups. The response area of GFAP staining did not show up in any of the four groups, indicating the inability of the hUC-MSCs to differentiate to astrocytes.
real-time Pcr results
After cell grafting, PCR was used to detect the mRNA expression of GFAP, MBP, and NF-H in each group. Ct was performed according to the format of 2 −Ct , the final data representing the amount ratio of GFAP-, MBP-, and NF-H-mRNA expression between the second, third, and fourth weeks and the first week in each group. In this study, real-time PCR showed a strong correlation with the immunofluorescence staining findings. In the co-transplantation group, presence of MBP-mRNA and NF-H-mRNA was evident, compared with the other three groups (DMEM, hSC, and hUC-MSC groups) (P , 0.05), while the differences of MBP-mRNA and NF-H-mRNA expression in the hSC or hUC-MSC transplantation groups did not show statistical significance (P . 0.05), in agreement with the immunofluorescence staining. In contrast, the differences of GFAP-mRNA among the four groups were considered not significant, but it was clear that the transplanted cells could decrease the formation of GFAP to some extent.
Western blot examination
To confirm the results of RT-PCR, Western blot analysis was performed and the results were in accordance with the immunofluorescence and PCR findings. In the co-transplantation group, MBP and NF-H expression were higher and GFAP was lower than in the other groups, with a significant statistical 
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hscs promoting neural differentiation of hUc-Mscs in spinal cord injury difference (P , 0.05); however, compared with the DMEM group, the expression of MBP and NF-H in the hSC or hUC-MSC transplantation groups showed no significant differences (P . 0.05). The results demonstrate that the protein expression of those neural markers had the same increased tendency with the mRNA.
Discussion
SCI is followed by primary breakup of axons and secondary inflammation response at the site of injury. The ability of intrinsic cell renewal, 8 even with the application of mitogenic agents such as epidermal growth factor and fibroblast growth factor-2, 9,10 is not sufficient for substantial recovery of the SCI. Based on recent studies, stem cell therapy is an option for the treatment strategy of SCI and shows preliminary promise.
SCs not only support axonal regeneration in the injured peripheral nervous system, but also promote axonal regrowth and myelin reconstruction in the injured central nervous system. SCs have been proven to have the ability to facilitate axonal regeneration with secreted neurotropic factors, such as BDNF and NGF. 12 The results of a previous experiment 13 showed that transplantation of autologous activated SCs could promote the recovery of hind limb locomotor function in injured rats and that the regenerative neurofilaments could pass through the injury site and make up the spinal cord cavity. Through co-culturing neural stem cells and SCs in vitro, SCs could promote the survival, regeneration, and neural differentiation of the neural stem cells.
14 HU-MSCs can be easily obtained, isolated, and processed without any ethical or legal problem, in contrast to embryonic or bone marrow stem cells. The fibroblast colony-forming unit of hUC-MSCs has a high isolation rate and short doubling time. 11, 15 For the other aspects, hUC-MSCs are immunologically compatible and capable of long-term survival in the host tissue. hUC-MSCs could also express the primitive stem cell-related marker protein. 16 Thus, hUC-MSCs are a promising candidate stem cell for the treatment of SCI. 17 However, another in vitro experiment indicated that hUC-MSCs could express neuron-specific proteins, such as microtubule-associated protein and neurofilament. Moreover, glutamate-invoking inward current has also been found in transformed cells, suggesting that the induced cells could differentiate into mature neurons. 18 In the present study, immunofluorescence staining demonstrated that co-transplantation of hSCs and hUCMSCs could promote hUC-MSC differentiation into neurons and glial cells, which was confirmed with RT-PCR and Western blot analysis. This might be a result of neurotropic factors secreted by the hSCs, which improved the inhibitory microenvironment of the injured spinal cord. 19 This result shows some accordance with the findings of Kadivar et al 20 and Koh et al, 21 who documented the potential capacities of human umbilical cord vein-derived MSCs differentiating into neural cells. In another aspect, hUC-MSC transdifferentiation with chemical agent is a quick induction process that has attracted much research attention. Wang et al 22 indicated that neuron-specific enolase and neurofilament M could be detected after culturing hUC-MSCs with basic fibroblast growth factor and low serum media plus butylated hydroxyanisole and dimethyl sulfoxide. This illustrates that these modifications could be a result of the induced chemical neurotropic factors. Since adult SCs can release neurotropic factors such as BDNF and NGF, 5 there is a great possibility that neuronal transdifferentiation of hUC-MSCs and recovery of neurological function could be obtained in vivo when they are grafted into neural tissue with the SCs after SCI. Moreover, the change in protein expression of MBP, NF-H, and GFAP in the co-transplantation group illustrates that the co-transplantation of hUC-MSCs and hSCs not only made up the loss of neurons and oligodendrocytes, but also inhibited the formation of glial scarring.
Conclusion
The present research demonstrates that hUC-MSCs can transdifferentiate into neurons and glial cells in vivo when co-cultured with hSCs in injured neural tissue. Therefore, it suggests that, as a cell therapy protocol, induced neural transdifferentiation procedures of hUC-MSCs in vitro may not be necessary, and the prospect of widespread application of hUC-MSCs and hSCs in the treatment of SCI is promising. 
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